The Engineer from University of Oxford started evaluating the possibility of building a company that provides end-to-end platform bringing data scientists, immunologists and immunotherapists, under a single roof and give them necessary tools to build vaccines to treat advanced stages of colon cancer.
from Moneycontrol http://bit.ly/2Y1yViE
No comments:
Post a Comment